Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens – Massachusetts General Hospital’s Bryan Lenneman, Ph.D.
Please join us in person or on Zoom for the March 2023 Levy CIMAR Science Lunch seminar from Bryan Lenneman, Ph.D., a Research Fellow at Massachusetts General Hospital. Dr. Lenneman will present on “Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens.”
Dr. Lenneman’s research interests include utilizing synthetic biology to develop novel therapeutics against diseases associated with dysbiosis of the human gut microbial community. His work focuses on engineering bacteriophages as an alternative to conventional antibiotics for the removal of pathogenic bacteria and on developing probiotic bacteria as therapeutic additives to the gut microbiome.
Dr. Lenneman is a Research Fellow in MGH’s Christina Faherty Lab and was previously a Postdoctoral Associate in the Timothy Lu lab at MIT from 2019-2022. He obtained his Ph.D. in Genetics, Genomics, and Systems Biology at The University of Chicago in 2019.